August 3, 2011
by Ashley Gould Vice President Corporate Development & Chief Legal Officer, 23andMe Linda Avey and Anne Wojcicki created 23andMe based on a number of visions. They described one of these to me in early 2007, capturing my imagination and playing a large role in my decision to become a member of the [...]
May 10, 2011
Genetic research is a numbers game. The more people who contribute to the effort, the more powerful it gets. As our Sarcoma Community grows with survey responses and genetic data from participants, we learn more about sarcoma and people’s responses to treatment. We are over halfway to our goal of 1,000 [...]
March 1, 2011
There is strength in numbers. With the help of our participants, we are well on our way to achieving our 1,000 person Sarcoma Community milestone. Thank you! We have over 500 individuals who have joined our sarcoma group from all over the world and with ties to several different patient organizations. Just [...]
January 25, 2011
Leading Personal Genomics Company Engages the Worldwide Sarcoma Community for Research and Welcomes Leading Sarcoma Researchers and Clinicians as Advisors 23andMe’s sarcoma research efforts are well underway with collection of both phenotypic and genetic data from 500 individuals diagnosed with sarcoma [...]
March 19, 2009
PET scans showing dopamine activity in a normal brain and a Parkinson's patient's before and after treatment with a therapeutic implant. More than a million Americans have Parkinson's disease, and another 50,000 are diagnosed each year. Scientists know that many of the characteristic symptoms of [...]
